category business-and-finance 
Pharmaceutical Technology
DECEMBER 19, 2022
Business Expansion. Business Expansion is one of our largest categories and looks at the core functions of business operations within the sector. The Environmental category aims to highlight companies that are undertaking projects that reduce their impact on the natural environment or contribute to its general health.
pharmaphorum
OCTOBER 5, 2022
After a bumper 2021, the fall-off in digital health financing deals that started to appear early this year has continued, with the three month to send September the lowest funded quarter since the tail end of 2019. The changing appetites can be seen by breaking the deals down into categories.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
DECEMBER 22, 2022
Our programme is designed to highlight excellence within the sector by looking at a range of corporate activities including deals, business projects and company initiatives, both internal and in the community. Business Expansion. The programme provides a platform to recognise the people and companies that are driving change.
Pharmaceutical Technology
MAY 17, 2023
The programme provides a platform to recognize the people and companies that are driving change and is powered by the business intelligence of GlobalData. Success and independent recognition attracts interest and helps win new business. Our brand is recognized as a mark of excellence in the industry.
pharmaphorum
NOVEMBER 7, 2022
With more than a decade of experience leading and scaling managed care organisations, Grabski is a seasoned business leader and finance executive. He has also served as VP of Strategy and Execution, primarily responsible for adapting UHC’s Medicare Advantage business to the changes from the ACA. Ben Grabski, Lumeris.
pharmaphorum
JULY 12, 2022
The buoyant financing environment for digital health companies that took off during the pandemic looks like it has come to an end, according to new figures from market watcher Rock Health. It may be that some of the more crowded categories will see consolidation start to gather momentum, with larger players buying smaller competitors.
pharmaphorum
AUGUST 26, 2021
A merger between two digital mental health companies – Headspace and Ginger – will create a $3 billion giant in a category that has been growing at breakneck speed as a result of the COVID-19 pandemic. The company raised $100 million in a Series E financing in March, bringing its total funding to more than $220 million.
Expert insights. Personalized for you.
52 
Let's personalize your content